Page 27 - Diagnostics Devices Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostics devices segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostics Devices Segment Today - Breaking & Trending Today

Large-scale study identifies new approach to early Alzheimer's detection

Digital memory test and a blood sample - this combination will be tested for its potential to identify early Alzheimer's disease in a new research study. Over a hundred healthcare centers are part of the study that is now inviting participants to sign up. At least 3,000, preferably many more participants are needed for the study to be successful. ....

Vastra Gotalands Lan , Silke Kern , Kaj Blennow , Henrik Zetterberg , Gothenburg University , Sahlgrenska Academy , Sahlgrenska University Hospital , University Of Gothenburg , Michael Sch , Lzheimer 39s Disease , Primary Care ,

Sound decision: Masimo to split off consumer business

Less than two years after acquiring Sound United for $1.025 billion, Masimo Corp. plans to hive off the consumer audio subsidiary along with consumer health products such as its Stork baby monitor and Freedom smart watch and band. The “rushed” announcement made Friday “came after being informed that Politan intended to nominate directors this week,” said activist investor Politan Capital Management. Politan, which owns 8.9% of the company, secured two board seats in a highly contentious proxy battle last year and nominated two more on Monday morning. ....

Masimo Corp , Sound United , Politan Capital , Bioworld Medtech , Masimo Corp , Spin Off , Sound United Llc , Apple Inc , Deals Andm Amp A ,

Alamar Biosciences scoops up $128M for proteomics platform

Alamar Biosciences Inc.’s substantially oversubscribed series C pushed the company’s total funds raised to $250 million. The company closed the first $100 million on Feb. 26 and expects to close an additional $28 million within 30 days. The target for the series C was $100 million. The funds will be used to drive market adoption of its Argo HT system and nucleic acid linked immune-sandwich assay sequencing (NULISAseq) inflammation panel 250 for deep profiling of immune response. ....

Alamar Biosciences Inc , Alamar Biosciences , Bioworld Medtech , Alamar Biosciences Inc , Argo Ht , Nulisaseq 250 , Series C ,